Eton Pharmaceuticals Files Annual Proxy Statement
Ticker: ETON · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1710340
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Eton Pharma dropped its DEF 14A. Proxy stuff, exec pay details inside.
AI Summary
Eton Pharmaceuticals, Inc. filed a DEF 14A on April 25, 2025, for the fiscal year ending December 31, 2024. The filing provides details on executive compensation and other corporate governance matters. The company is based in Deer Park, IL, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation, director elections, and other significant corporate actions, enabling informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing detailing executive compensation and corporate governance, not indicating new financial risks.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Filer
- 20250425 (date) — Filing Date
- 20250610 (date) — Period of Report
- 2024-12-31 (date) — Fiscal Year End
- Deer Park, IL (location) — Company Business Address
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors, executive compensation, and other proposals.
When is the period of report for this Eton Pharmaceuticals filing?
The period of report for this filing is June 10, 2025.
What is Eton Pharmaceuticals' Standard Industrial Classification (SIC) code?
Eton Pharmaceuticals' SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Eton Pharmaceuticals located?
Eton Pharmaceuticals is located at 21925 W. Field Parkway, Suite 235, Deer Park, IL 60010-7278.
What is the filing date of this DEF 14A?
The filing date of this DEF 14A is April 25, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).